v3.25.2
CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Loss from continuing operations $ (5,433) $ (9,052) [1]
Adjustments to the profit or loss items:    
Depreciation and amortization of property, plant and equipment and right-of-use-assets 600 731
Share-based compensation 472 617
Remeasurement of Convertible SAFE (345) 24
Net financing expenses (income) 156 (364)
Loss (gain) from sale of property, plant and equipment (194) 524
Amortization of deferred expenses related to issuance of warrants 656 0
Remeasurement of pre-funded warrants and warrants (1,318) 0
Share of loss of an associate 67 20
Taxes on income 1 1
Adjustments to the profit or loss items 95 1,553
Changes in asset and liability items:    
Decrease (increase) in trade receivables (63) 119
Decrease (increase) in other receivables and prepaid expenses 1,369 (627)
Increase in inventories (601) (228)
Decrease in trade payables (369) (716)
Decrease in employees and payroll accruals (124) (120)
Decrease in other payables (458) (94)
Decrease in deferred revenues and other advances (351) (105)
Changes in asset and liability (597) (1,771)
Cash received (paid) during the period for:    
Interest received 176 402
Interest paid (98) (41)
Taxes paid (11) 0
Net cash used in continuing operating activities (5,868) (8,909)
Net cash used in operating activities of discontinued operations (1,615) (656)
Net cash used in operating activities (7,483) (9,565)
Cash flows from investing activities:    
Purchase of property, plant and equipment (123) (166)
Proceeds from sale of property, plant and equipment 0 10
Proceeds from finance sub-lease asset 17 0
Withdrawal from (investment in) bank deposits, net (3,328) 1,024
Net cash provided by (used in) continuing investing activities (3,434) 868
Net cash used in investing activities of discontinued operations 0 (2,020)
Net cash used in investing activities (3,434) (1,152)
Cash flows from financing activities:    
Proceeds from issuance of ordinary shares, net of issuance expenses 4,283 86
Repayment of lease liability (283) (470)
Repayment of government grants (122) (142)
Net cash provided by (used in) continuing financing activities 3,878 (526)
Net cash provided by financing activities of discontinued operations 112 8
Net cash provided by (used in) financing activities 3,990 (518)
Exchange rate differences - cash and cash equivalent balances 25 (53)
Decrease in cash and cash equivalents (6,902) (11,288)
Cash and cash equivalents, beginning of the period 15,301 20,772
Cash and cash equivalents presented in assets held for sale (70) 0
Cash and cash equivalents, end of the period 8,329 9,484
Significant non-cash activities:    
Purchase of property, plant and equipment, net 11 15
Investment in affiliated company with corresponding deferred revenues 0 120
Exercise of pre-funded warrants 389 0
Right-of-use asset recognized with corresponding lease liability 207 184
Derecognition of right-of-use asset under a finance lease $ 13 $ 0
[1] Reclassified to conform to the current period presentation, following the classification of certain operations as discontinued operations.